Spot gold fell nearly $10 intraday to $4,056/oz.

The implantable brain–computer interface (BCI) hand motor function compensation system NEO, developed by Borui Kang Medical Technology (Shanghai) Co., Ltd., received market approval from Shanghai regulators and underwent its first commercial clinical surgery on July 13 at Huashan Hospital affiliated with Fudan University. Intraoperative testing showed the system recorded stable, high-quality epidural EEG signals. The patient is reported hemodynamically stable post‑op. Authorities describe NEO as a world‑first product.

Korean outlet DealSite, citing semiconductor industry sources, reports Samsung Electronics has not received NVIDIA mass-production orders for HBM4; its revenue from NVIDIA is limited to paid test samples. Rival SK Hynix has started mass shipments of 12-layer HBM4 to NVIDIA and is entering a capacity ramp. SK Hynix plans to expand HBM4 shipments from September to meet NVIDIA’s high-end compute chip demand.